In summary, the model replicates the variability in CT26 tumor volume-time profiles by incorporating inter-individual variations in three parameters, namely, CD8+ T cell proliferation half-life, tumor cell proliferation rate, and tumor carrying capacity. The gene discussed is CD8A; the disease is neoplasm.